Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma
Clinical trial NCT06826118 · RECRUITING
Trial details
- NCT number
- NCT06826118
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-08
- Primary completion
- 2026-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.